Failure to repair the c.338C>T mutation in carnitine palmitoyl transferase 2 deficient skin fibroblasts using chimeraplasty.

[1]  O. Igoucheva,et al.  Oligonucleotide-directed mutagenesis and targeted gene correction: a mechanistic point of view. , 2004, Current molecular medicine.

[2]  I. Graham,et al.  Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts) , 2003, The journal of gene medicine.

[3]  B. Cormand,et al.  Unsuccessful chimeraplast strategy for the correction of a mutation causing Gaucher disease. , 2003, Blood cells, molecules & diseases.

[4]  G. Taubes.  The Strange Case of Chimeraplasty , 2002, Science.

[5]  A. Orpana,et al.  Accuracy in amplification , 2001, Nature Biotechnology.

[6]  J. S. Owen,et al.  Gene repair validation , 2001, Nature Biotechnology.

[7]  H. Scheffer,et al.  Persistent failures in gene repair , 2001, Nature Biotechnology.

[8]  M. Rice,et al.  The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. , 2000, Nucleic acids research.

[9]  R. Kumar,et al.  A plausible mechanism for gene correction by chimeric oligonucleotides. , 2000, Biochemistry.

[10]  C. Steer,et al.  Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Blombäck,et al.  Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed. , 1998, Antisense & nucleic acid drug development.

[12]  C. V. D. Schoot,et al.  Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes , 1998, Leukemia.

[13]  V. Alexeev,et al.  Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide , 1998, Nature Biotechnology.

[14]  C. Steer,et al.  In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides , 1998, Nature Medicine.

[15]  N. Manning,et al.  Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid , 1997, Journal of Inherited Metabolic Disease.

[16]  C. Steer,et al.  Targeted nucleotide exchange in the alkaline phosphatase gene of HuH‐7 cells mediated by a chimeric RNA/DNA oligonucleotide , 1997, Hepatology.

[17]  M. Rice,et al.  Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide , 1996, Science.

[18]  E. Kmiec,et al.  Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Carpenter,et al.  Differential diagnosis of hydroxydicarboxylic aciduria based on release of3H2O from [9,10-3H]myristic and [9,10-3H]palmitic acids by intact cultured fibroblasts , 1992, Journal of Inherited Metabolic Disease.

[20]  C Summers,et al.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.

[21]  H. Deckmyn,et al.  False positive results in chimeraplasty for von Willebrand Disease. , 2007, Thrombosis research.